Cargando…
Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells
Colorectal cancer (CRC) has been proven to be highly reliant on arginine availability. Limiting arginine-rich foods or treating patients with arginine-depleting enzymes arginine deiminase (ADI) or arginase can suppress colon cancer. However, arginase and ADI are not the best drug candidates for CRC....
Autores principales: | Wei, Xinlei, Chow, Ho-Yin, Chong, Hiu-Chi, Leung, Siu-Lun, Ho, Mei-Ki, Lee, Man-Yuen, Leung, Yun-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531272/ https://www.ncbi.nlm.nih.gov/pubmed/37762044 http://dx.doi.org/10.3390/ijms241813741 |
Ejemplares similares
-
Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer
por: Chung, Sai-Fung, et al.
Publicado: (2020) -
Arginine Decarboxylase Is Essential for Pneumococcal Stress Responses
por: Frances Nakamya, Mary, et al.
Publicado: (2021) -
Hydroxylamine Analogue of Agmatine: Magic Bullet for Arginine Decarboxylase
por: Hyvönen, Mervi T., et al.
Publicado: (2020) -
Functional roles of ornithine decarboxylase and arginine decarboxylase during the peri-implantation period of pregnancy in sheep
por: Lenis, Yasser Y., et al.
Publicado: (2018) -
Neofunctionalization of S-adenosylmethionine decarboxylase into pyruvoyl-dependent L-ornithine and L-arginine decarboxylases is widespread in bacteria and archaea
por: Li, Bin, et al.
Publicado: (2023)